Financial Performance - Revenue for the six months ended December 31, 2023, was HK$83,563,000, representing an increase of 58.5% compared to HK$52,992,000 for the same period in 2022[8]. - Gross profit for the period was HK$50,860,000, up 68.5% from HK$30,141,000 in the previous period[8]. - Profit for the period increased to HK$5,682,000, a rise of 35.3% from HK$4,199,000 in the previous period[11]. - Basic and diluted earnings per share were HK2.18 cents, compared to HK1.61 cents for the same period last year, reflecting a growth of 35.4%[11]. - Total comprehensive income for the period was HK$6,292,000, compared to a comprehensive expense of HK$4,862,000 in the previous period[11]. - Profit before taxation for the six months ended December 31, 2023, was HK$6,777,000, an increase from HK$4,245,000 in 2022, representing a growth of approximately 59.5%[20]. - Profit for the period attributable to owners of the Company increased to HK$5,682,000 for the six months ended 31 December 2023, compared to HK$4,199,000 in 2022, representing a growth of approximately 35.3%[56]. Assets and Liabilities - Non-current assets increased to HK$53,812,000 as of December 31, 2023, from HK$48,388,000 as of June 30, 2023[15]. - Current assets decreased to HK$163,555,000 from HK$175,563,000 as of June 30, 2023, primarily due to a reduction in inventories[15]. - Net assets rose to HK$140,885,000 as of December 31, 2023, compared to HK$134,583,000 as of June 30, 2023[15]. - The total equity as of December 31, 2023, was negative HK$140,885,000, a slight improvement from negative HK$128,417,000 at the end of 2022[17]. - Current liabilities decreased to approximately HK$73 million from HK$87 million[191]. - The company maintained a healthy level of financial liquidity with net current assets of approximately HK$89 million as of December 31, 2023[191]. Cash Flow - Net cash generated from operating activities for the six months ended December 31, 2023, was HK$11,115,000, compared to a net cash outflow of HK$28,907,000 in the previous year[20]. - Cash and cash equivalents at the end of the period increased to HK$105,760,000 from HK$72,646,000, marking an increase of approximately 45.5%[20]. - The effect of foreign exchange rate changes resulted in an increase of HK$1,569,000 in cash and cash equivalents during the period[20]. Expenses - Distribution costs increased to HK$13,826,000 from HK$11,793,000, reflecting a rise of 17.2% year-on-year[8]. - General and administrative expenses increased by approximately 17.6% to approximately HK$20 million for the six months ended 31 December 2023, compared to approximately HK$17 million in the previous year[115][120]. - The company incurred finance costs of HK$294,000 for the period, up from HK$35,000 in the previous year, indicating increased borrowing costs[20]. Revenue Segmentation - Revenue from technology system sales, including software licensing, was HK$48,083,000 for the period, up from HK$21,967,000 in the previous year, marking a significant increase of about 119.5%[39]. - The segment result for technology system sales was HK$20,137,000, compared to HK$3,333,000 in the prior period, indicating a substantial improvement in performance[42]. - The total revenue recognized at a point in time was HK$48,083,000, while revenue recognized over time amounted to HK$35,480,000 for the period[42]. Investments and Fair Value - The company reported a fair value loss on financial assets of HK$12,248,000 during the period, compared to a gain of HK$3,153,000 in the previous period[8]. - The fair value of investment property as of 31 December 2023 was HK$6,001,000, which was valued using the direct comparison method[71]. - As of 31 December 2023, the fair value of listed equity investments in Hong Kong classified as financial assets at fair value through profit or loss was approximately HK$1.4 million, down from approximately HK$14.0 million[123][124]. Market and Strategic Developments - The UK remains the largest market for the company, exceeding revenue and sales intake targets by the end of December 2023[177]. - The subsidiary in Germany achieved record revenue levels in the first half of the fiscal year, attributed to fulfilling order backlogs and a contract with Klinikum der Universität München[179]. - Sales in Oceania, particularly in Australia, showed significant improvement, making it the third largest market outside the UK, following Germany and the Irish Republic[180]. - The US market continues to underperform, with no substantial revenue growth expected in the short term, but the company is working on a strategy for long-term improvement[181]. Corporate Governance - The Board of directors resolved not to pay any interim dividend for the six months ended 31 December 2023, consistent with the decision in 2022[59]. - Key management personnel remuneration for the six months ended 31 December 2023 totaled approximately HK$5.8 million, an increase from approximately HK$3.1 million in the previous period[109][118].
看通集团(01059) - 2024 - 中期业绩